| pubmed-article:19370305 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0008312 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0042105 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0231221 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:19370305 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:19370305 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19370305 | pubmed:dateCreated | 2009-6-11 | lld:pubmed |
| pubmed-article:19370305 | pubmed:abstractText | Among patients with asymptomatic primary biliary cirrhosis (a-PBC), a substantial portion ultimately develop symptoms suggestive of liver injury. Prognostic variables to distinguish patients likely to become symptomatic from patients who will remain asymptomatic need to be identified. We examined the impact of biochemical response to ursodeoxycholic acid in the development of symptoms in patients with a-PBC. | lld:pubmed |
| pubmed-article:19370305 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19370305 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19370305 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19370305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19370305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19370305 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19370305 | pubmed:issn | 0944-1174 | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:AbeMasanoriM | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:OnjiMorikazuM | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:MatsuuraBunzo... | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:MurataYosukeY | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:HiasaYoichiY | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:HamadaMahoM | lld:pubmed |
| pubmed-article:19370305 | pubmed:author | pubmed-author:AzemotoNobuak... | lld:pubmed |
| pubmed-article:19370305 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19370305 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:19370305 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19370305 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19370305 | pubmed:pagination | 630-4 | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:meshHeading | pubmed-meshheading:19370305... | lld:pubmed |
| pubmed-article:19370305 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19370305 | pubmed:articleTitle | Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. | lld:pubmed |
| pubmed-article:19370305 | pubmed:affiliation | Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, To-on, Ehime 791-0295, Japan. | lld:pubmed |
| pubmed-article:19370305 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19370305 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
